HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shalev, A. Articles by Meier, C. A Search for Related Content PubMed Articles by Shalev, A. Articles by Meier, C. A

Peroxisome proliferator-activated receptors: a nuclear hormone receptor involved in adipocyte differentiation and lipid homeostasis

The peroxisome proliferator-activated receptors (PPARs) were, until recently, orphan receptors with no known ligand and an unclear physiological role. Since the recent discovery of PPAR ligands and their effect on adipocyte differentiation, this receptor is now speculated to be possibly implicated in the pathogenesis of insulin resistance and obesity. The PPARs belong to the superfamily of nuclear hormone receptors (together with steroid, thyroid hormone, retinoid and vitamin D receptors) which act as transcription factors. PPARs recognize and bind to specific DNA sequences (response elements) in the promoter region of target genes as a heterodimer with the 9-cis-retinoic acid receptor RXR. While PPAR can bind to DNA in the unliganded state, ligand binding is essential for activation of the PPAR and the resulting induction of target gene expression. The known target genes are mostly coding for lipolytic enzymes involved in peroxisomal fatty acid β-oxidation.

So far, three PPAR subtypes

This article has been cited by other articles:

				L. H. Hansen, B. Madsen, B. Teisner, J. H. Nielsen, and N. Billestrup Characterization of the Inhibitory Effect of Growth Hormone on Primary Preadipocyte Differentiation Mol. Endocrinol., August 1, 1998; 12(8): 1140 - 1149. [Abstract] [Full Text]